Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 604-636-5 | CAS number: 148477-71-8
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Hydrolysis
Administrative data
Link to relevant study record(s)
- Endpoint:
- hydrolysis
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- guideline study
- Justification for type of information:
- This experimental study report is reliable for use in the risk assessment as it has been conducted by a trusted laboratory, under GLP and following EPA, EEC and SETAC Guidelines relevant at the time of the study being conducted. There are no stated deviations from the current guidelines.
- Qualifier:
- according to guideline
- Guideline:
- other: US EPA, Pesticide Assessment Guidelines, Subdivision N, Chemistry: Environmental Fate §161-1 Hydrolysis Studies
- Version / remarks:
- Oct. 18, 1982.
- Deviations:
- not specified
- Qualifier:
- according to guideline
- Guideline:
- other: EC Commission Directive 95/36/EC amending Council Directive 91/414/EEC Annexes I and II, Fate and Behavior in the Environment
- Version / remarks:
- July 14, 1995.
- Deviations:
- not specified
- Qualifier:
- according to guideline
- Guideline:
- other: SETAC Procedures for Assessing the Environmental Fate and Ecotoxicity of Pesticides
- Version / remarks:
- March 1995
- Deviations:
- not specified
- GLP compliance:
- yes (incl. QA statement)
- Radiolabelling:
- yes
- Remarks:
- [dihydrofuranone-3-14C]Spirodiclofen
- Analytical monitoring:
- yes
- Details on sampling:
- Samples (7.5 mL of buffer in a crimp top glass vessel) were analyzed at 0, 2, 4, 7, 14, 21, and 30 days. Additional samples were taken for pH 9 at 1 and 6 hours and 3 days. For processing of the test solutions (7.5 mL), three aliquots (500 µL) were analyzed by LSC, and two aliquots (500 µL) were analyzed by TLC. Acetonitrile (5 mL) was added to the remaining test solution (5 mL), to solubilize adsorbed radioactivity from the glass walls, and two aliquots (500 µL) were analyzed by LSC.
- Buffers:
- 0.01 M acetate buffer (pH 4) - A 0.04 M stock solution of acetate buffer was prepared by dissolving 1.36 g CH3CO2Na x 3 H20 in 250 mL of water. The pH of this solution was measured with a pH-electrode and adjusted to pH 4.0 using acetic acid. The final 0.01 M acetate buffer solution was prepared by diluting the 0.04 M buffer solution to the desired molarity with purified water (1:3 buffer:water; v/v) and sterilized
0.01 M TRlS buffer (pH 7) - A 0.05 M TRlS buffer stock solution was prepared by mixing 50 mL of a 0.1 M tris(hydroxymethyl)aminomethane solution (12.1 g/L H20) with 46 mL of 0.1 N hydrochloric acid (3.65 g HCl/L H20) followed by dilution to 100 mL with purified water. The pH of this solution was measured with a pH electrode and adjusted to pH 7.0 using 0.1 N hydrochloric acid and 0.1 N sodium hydroxide, respectively. The final 0.01 M TRlS buffer solution was prepared by diluting to the desired molarity of 0.01 M with purified water (1:4 buffer:water; v/v) and sterilized.
0.01 M borate buffer (pH 9) - A 0.02 M borate buffer stock solution was prepared by dissolving 0.62 g boric acid (H3BO3) and 0.75 g KCl in water to a final volume of 250 mL. To 125 mL of this solution 53 mL of a 0.04 M sodium hydroxide solution (1.6 g NaOH/L H20) was added, and the mixture was diluted with water to a total volume of 250 mL. The pH of this solution was measured with a pH electrode and adjusted to pH 9.0 using 0.4 M sodium hydroxide or boric acid, respectively. The final 0.01 M borate buffer solution was prepared by diluting the 0.04 M buffer stock solution to the desired molarity of 0.01 M with purified water (1:1 buffer:water; v/v) and sterilized. - Details on test conditions:
- Test concentrations (mg a.i./L):
nominal: 0.025 mg a.i./L (50% of maximum water solubility).
measured: 0.0235 mg/L (pH 4); 0.0266 mg/L (pH 7); 0.0250 mg/L (pH 9)
Preparation of test medium:
volume used/treatment: 7.5 mL of the corresponding buffer solution.
method of sterilization: Buffer solutions and all glass ware used for preparation of solutions and sampling procedure were sterilized by steam pressure sterilization before application of the test substance.
co-solvent (type/concentration): Dose was applied in 75 µL of acetonitrile (ACN) to 7.5 mL of the corresponding buffer giving a final concentration of 1% ACN (v/v).
Test apparatus (type/material/volume): 10 mL glass crimp-top vials filled with ca. 7.5 mL test solution and stoppered using crimp caps with Teflon-faced septa. The crimp caps of the samples were marked with different colors to distinguish between the pH values.
Traps for volatiles: no traps. Closed test system with crimp caps to maintain sterility.
Is there any indication of the test material adsorbing to the walls of the test apparatus?: yes. Glassware was silanized prior to sterilization and additional samples were prepared and analyzed to ascertain degree of binding. Each flask was rinsed with ACN, and the rinse was radioassayed. Additional flasks were prepared for the analysis of the glass-bound (i.e., ACN soluble) residues.
Experimental conditions:
Temperature (ºC): 25ºC (pre-test performed at 50ºC).
Lighting: dark, no lights. - Duration:
- 30 d
- pH:
- 9
- Temp.:
- 25 °C
- Initial conc. measured:
- 0.025 mg/L
- Duration:
- 30 d
- pH:
- 7
- Temp.:
- 25 °C
- Initial conc. measured:
- 0.027 mg/L
- Duration:
- 30 d
- pH:
- 4
- Temp.:
- 25 °C
- Initial conc. measured:
- 0.024 mg/L
- Number of replicates:
- 2 per interval for analysis for quantitation of radioactive residues.
- Preliminary study:
- In a preliminary test, the hydrolysis
study was conducted at 50ºC using the same procedures and buffers as were used in the test at
25ºC. The half-lives at 50ºC and pH 4, 7, and 9 were 3.1, 2.5, and 0.4 days, respectively. Using
the data from the hydrolysis at 50ºC and 25ºC, the half-lives of Spirodiclofen at 20ºC and pH 4, 7,
and 9 were calculated via the Arrhenius equation at 119.6, 52.1, and 2.5 days, respectively. - Transformation products:
- yes
- No.:
- #1
- % Recovery:
- 97.7 - 106.7
- pH:
- 9
- Temp.:
- 25 °C
- Duration:
- >= 0 - <= 30 d
- Remarks on result:
- other: recovered radioactivity
- % Recovery:
- 97.4 - 103.5
- pH:
- 7
- Temp.:
- 25 °C
- Duration:
- >= 0 - <= 30 d
- Remarks on result:
- other: recovered radioactivity
- % Recovery:
- 98.8 - 103.1
- pH:
- 4
- Temp.:
- 25 °C
- Duration:
- >= 0 - <= 30 d
- Remarks on result:
- other: recovered radioactivity
- Key result
- pH:
- 9
- Temp.:
- 25 °C
- DT50:
- 1.9 d
- Type:
- (pseudo-)first order (= half-life)
- Key result
- pH:
- 7
- Temp.:
- 25 °C
- DT50:
- 30.8 d
- Type:
- (pseudo-)first order (= half-life)
- Key result
- pH:
- 4
- Temp.:
- 25 °C
- DT50:
- 63.6 d
- Type:
- (pseudo-)first order (= half-life)
- Details on results:
- TEST CONDITIONS: The pH and temperature and other experimental conditions were maintained throughout the study. The initial pH 7 hydrolysis did not maintain sterility, but this was repeated and sterility was maintained on the second attempt. Residues of Spirodiclofen adsorbed to the walls of the glassware during the study. These residues were shown to be comprised of only one component, Spirodiclofen. A minor artifact was formed during the analysis of the major degradate, Spirodiclofen-Enol, and additional experiments performed with a standard of the Enol clearly showed that this product (M2, Spirodiclofen-Lactide) was an artifact produced during chromatographic analyses.
MASS BALANCE: Total radiocarbon recovery ranged from 98.8 to 103.1% of the applied amount at pH 4, 97.4 to 103.5% of the applied amount at pH 7, and 97.7 to 106.7% of the applied amount at pH 9.
TRANSFORMATION OF PARENT COMPOUND: At the end of the study, the concentration of the parent compound decreased from 94.9% at day 0 to 70.3% of the initial at pH 4, 101.3 to 51.0% of the initial at pH 7, and 100.4 to 1.1% of the initial at pH 9.
TRANSFORMATION PRODUCTS: The only transformation product detected at pH 4, 7, and 9 was Spirodiclofen-Enol [3-(2,4-dichlorophenyl)-4-hydroxy-1-oxaspiro[4.5]dec-3-en2-one]. Spirodiclofen-Enol reached a maximum concentration of 28.9, 52.2, and 100.8% of the applied amount observed at test termination at pH 4, 7, and 9, respectively. A minor transformation product, M2, was shown to be an artifact formed during chromatographic analysis of Spirodiclofen-Enol. No volatile compounds were formed during the study, and no unidentified radioactivity was observed at any pH.
PATHWAYS: The hydrolysis pathway for Spirodiclofen involved the hydrolysis of an ester sidechain to form Spirodiclofen-Enol.
HALF-LIFE: The half-lives for the hydrolysis of [dihydrofuranone-3-14C]Spirodiclofen at pH 4, 7, and 9 at 50ºC and 25ºC were determined using first-order kinetics. The half-lives for the hydrolysis of [dihydrofuranone-3-14C]Spirodiclofen at pH 4, 7, and 9 at 20ºC were calculated using the Arrhenius equation. - Validity criteria fulfilled:
- yes
- Conclusions:
- The half-life (DT50) of the test substance at 25°C was determined to be 63.6 days at pH 4, 30.8 days at pH 7 and 1.9 days at pH 9.
- Executive summary:
Hydrolysis of [dihydrofuranone-3-14C]Spirodiclofen at 0.025 mg a.i/L was studied in the dark at 25°C in sterile aqueous buffered solutions at pH 4 (0.01 M acetate buffer), pH 7 (0.01 M TRlS buffer) and pH 9 (pH 9: 0.01 M borate buffer) for a maximum of 30 days. The experiment was conducted in accordance with the EPA Pesticide Assessment Guideline, Subdivision N, Section §161-1, 1982 as well as EC Commission Directive 95/36/EC, 1995, and in compliance with the OECD–GLP standards. Samples were analyzed at 0, 2, 4, 7, 14, 21, and 30 days (pH 4); 0, 1, 3, 7, 14, 21, and 30 days (pH 7), and 0, 0.1, 0.25, 1, 2, 3, 4, 7, 14, 21, and 30 days (pH 9). Aliquots of the solutions were analyzed directly after addition of acetic acid which was used to stablilize residues of Spirodiclofen. Due to the tendency of Spirodiclofen to adsorb on glass, all glassware were silanized. The radioactive components in the buffer solutions were separated and quantitated using two different reverse phase TLC systems, and the identification/confirmation of radioactive residues was performed either by co-chromatography with reference substances using silica TLC (three systems) or by LC-MS.
The radioactivity balance was 101.0 ± 1.4, 100.2 ± 2.1, and 102.3 ± 2.7% of the applied at pH 4, pH 7 and pH 9, respectively. At test termination, the concentration of the parent compound decreased from 94.9% at day 0, to 70.3% of the initial at pH 4, from 101.3 to 51.0% of the initial at pH 7, and from 100.4 to 1.1% of the initial at pH 9. The only transformation product detected at pH 4, 7, and 9 was Spirodiclofen-Enol [3-(2,4-dichlorophenyl)-4-hydroxy-1-oxaspiro[4.5]dec-3-en-2-one]. Spirodiclofen-Enol reached a maximum concentration of 28.9, 52.2, and 100.8% of the applied amount observed at test termination at pH 4, 7, and 9, respectively. A minor transformation product, M2, was shown to be an artifact formed during chromatographic analysis of Spirodiclofen-Enol. No volatile compounds were formed during the study, and no unidentified radioactivity was observed at any pH. The half-lives for the hydrolysis of [dihydrofuranone-3-14C]Spirodiclofen at pH 4, 7, and 9 at 50ºC and 25ºC were determined using first-order kinetics. The half-lives for the hydrolysis of [dihydrofuranone-3-14C]Spirodiclofen at pH 4, 7, and 9 at 20ºC were calculated using the Arrhenius equation.
In a preliminary test, the hydrolysis study was conducted at 50ºC using the same procedures and buffers as were used in the test at 25ºC. The half-lives at 50ºC and pH 4, 7, and 9 were 3.1, 2.5, and 0.4 days, respectively. Using the data from the hydrolysis at 50ºC and 25ºC, the half-lives of Spirodiclofen at 20ºC and pH 4, 7, and 9 were calculated via the Arrhenius equation at 119.6, 52.1, and 2.5 days, respectively. Data from the additional samples that were analyzed for the identification of glass-adsorbed radioactivity clearly demonstrated that all of the glass-bound (i.e., ACN soluble) residues were Spirodiclofen.The large scale hydrolyses provided material that was used for LC/MS confirmation of Spirodiclofen-Enol and Spirodiclofen-Lactide. Additionally, data from these samples and from the chromatography of a Spirodiclofen-Enol standard clearly showed that Spirodiclofen-Lactide was an artifact that formed in variable amounts during chromatographic analysis of the Enol. This study is classified acceptable and satisfies the guideline requirement for hydrolysis study.
Reference
Table 1: Hydrolysis of [dihydrofuranone-3-14C]Spirodiclofen, expressed as % applied radioactivity, at pH 4
Compound | day 0 | day 2 | day 4 | day 7 | day 14 | day 21 | day 30 |
Spirodiclofen | 94.9 | 93.6 | 91.6 | 91.5 | 82.7 | 73.6 | 70.3 |
Spirodiclofen-Enol | 4.6 | 7.4 | 9.8 | 8.4 | 16.8 | 27.5 | 28.9 |
Unidentified radioactivity | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
Volatiles (CO2 and VOCs) | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
Total % recovery | 99.5 | 101.0 | 101.4 | 99.9 | 99.5 | 101.1 | 99.2 |
Table 2: Hydrolysis of [dihydrofuranone-3-14C]Spirodiclofen, expressed as % applied radioactivity, at pH 7.
Compound | day 0 | day 1 | day 3 | day 7 | day 14 | day 21 | day 30 |
Spirodiclofen | 101.3 | 95.8 | 87.3 | 84.1 | 70.9 | 58.6 | 51.0 |
Spirodiclofen-Enol | 0.7 | 1.9 | 12.5 | 16.7 | 27.6 | 40.4 | 52.2 |
Unidentified radioactivity | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
Volatiles (CO2 and VOCs) | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
Total % recovery | 102.0 | 97.7 | 99.8 | 100.8 | 98.5 | 99.0 | 103.2 |
Table 3: Hydrolysis of [dihydrofuranone-3-14C]Spirodiclofen, expressed as % applied radioactivity, at pH 9.
Compound | day 0 | day 0.1 | day 0.25 | day 1 | day 2 | day 3 | day 4 | day 7 | day 14 | day 21 | day 30 |
Spirodiclofen | 100.4 | 94.3 | 82.5 | 62.5 | 43.6 | 27.6 | 17.5 | 7.7 | 2.4 | 2.8 | 1.1 |
Spirodiclofen-Enol | 6.2 | 11.8 | 17.0 | 40.9 | 60.5 | 71.0 | 80.7 | 92.1 | 98.1 | 90.9 | 100.8 |
Unidentified radioactivity | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
Volatiles (CO2 and VOCs) | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
Total % recovery | 106.6 | 106.1 | 99.5 | 103.4 | 104.1 | 98.6 | 98.2 | 99.8 | 100.5 | 93.7 | 101.9 |
Table 4: Half Lives
Test Solution | Half-life [days] at 50ºC | Half-life [days] at 25ºC | Half-life [days] at 20ºC |
pH 4 (0.01 M acetate buffer) | 3.1 | 63.6 | 119.6 |
pH 7 (0.01 M TRlS buffer) | 2.5 | 30.8 | 52.1 |
pH 9 (0.01 M borate buffer) | 0.4 | 1.9 | 2.5 |
Table 5: First order half-lives
pH | half-life | Regression equation | R2 | DT50 | DT90 |
4 | 63.6 days | y = 4.5361 - 0.0109(x) | 0.9716 | 63.6 days | 211.3 days |
7 | 30.8 days | y = 4.5798 - 0.0225(x) | 0.9861 | 30.8 days | 102.4 days |
9 | 44.4 hours (1.9 days) | y = 4.5228 - 0.0156(x) | 0.989 | 44.4 hours (1.9 days) | 147.6 hours (6.2 days) |
Description of key information
The half-life (DT50) of the test substance at 25°C was determined to be 63.6 days at pH 4, 30.8 days at pH 7 and 1.9 days at pH 9.
Key value for chemical safety assessment
- Half-life for hydrolysis:
- 30.8 d
- at the temperature of:
- 25 °C
Additional information
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.